ArticleMicrobiology spectrum2026
Gut dysbiosis impairs HPA axis function and exacerbates post-stroke inflammation in high-fat diet-fed male mice.
Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
High-fat diet (HFD)-induced metabolic stress is associated with impaired hypothalamic-pituitary-adrenal (HPA) axis function, but its impact on stroke outcomes and the role of the gut microbiota remain unclear. In a mouse middle cerebral artery occlusion (MCAO) model, we found that HFD induced gut dysbiosis, suppressed hypothalamic CRH expression, and reduced circulating corticosterone, which in turn exacerbated neuroinflammation and neuronal apoptosis, and worsened neurological recovery. Interventions with fecal microbiota transplantation or supplementation of IMPORTANCE: Metabolic disorders such as obesity and high-fat diet exposure are known to worsen stroke outcomes, but the mechanisms connecting metabolic stress, gut microbiota alterations, and neuroendocrine dysfunction have not been well defined. Our data indicate that gut dysbiosis under HFD conditions is associated with HPA axis suppression and worse neuroinflammatory injury after stroke and that microbiota-targeted intervention can restore hormonal regulation and functional recovery. This highlights the gut microbiota-neuroendocrine interface as a promising area for therapeutic exploration in metabolically at-risk stroke patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.